# Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor

> **NCT04785222** · PHASE4 · UNKNOWN · sponsor: **Chiang Mai University** · enrollment: 63 (estimated)

## Conditions studied

- Intraoperative Pain Control

## Interventions

- **DRUG:** dexmedetomidine 5 mcg mixed with 0.5% plain bupivacaine

## Key facts

- **NCT ID:** NCT04785222
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2023-07
- **Final completion:** 2023-12
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785222, "Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04785222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*